Applicant, as named in the Orange Book

Biofrontera

Next listed expiry: Ameluz on 8 Dec 2043. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Ameluz aminolevulinic acid hydrochloride	aminolevulinic acid hydrochloride	208081	8 Dec 2043	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.